Correlation Between Quantum Genomics and ICeram SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Quantum Genomics and ICeram SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quantum Genomics and ICeram SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Quantum Genomics SA and ICeram SA, you can compare the effects of market volatilities on Quantum Genomics and ICeram SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quantum Genomics with a short position of ICeram SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quantum Genomics and ICeram SA.

Diversification Opportunities for Quantum Genomics and ICeram SA

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Quantum and ICeram is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Quantum Genomics SA and ICeram SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ICeram SA and Quantum Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quantum Genomics SA are associated (or correlated) with ICeram SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ICeram SA has no effect on the direction of Quantum Genomics i.e., Quantum Genomics and ICeram SA go up and down completely randomly.

Pair Corralation between Quantum Genomics and ICeram SA

Assuming the 90 days trading horizon Quantum Genomics SA is expected to generate 2.0 times more return on investment than ICeram SA. However, Quantum Genomics is 2.0 times more volatile than ICeram SA. It trades about 0.05 of its potential returns per unit of risk. ICeram SA is currently generating about -0.05 per unit of risk. If you would invest  15.00  in Quantum Genomics SA on September 3, 2024 and sell it today you would lose (7.79) from holding Quantum Genomics SA or give up 51.93% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.02%
ValuesDaily Returns

Quantum Genomics SA  vs.  ICeram SA

 Performance 
       Timeline  
Quantum Genomics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Quantum Genomics SA are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Quantum Genomics reported solid returns over the last few months and may actually be approaching a breakup point.
ICeram SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ICeram SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Quantum Genomics and ICeram SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Quantum Genomics and ICeram SA

The main advantage of trading using opposite Quantum Genomics and ICeram SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quantum Genomics position performs unexpectedly, ICeram SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ICeram SA will offset losses from the drop in ICeram SA's long position.
The idea behind Quantum Genomics SA and ICeram SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Stocks Directory
Find actively traded stocks across global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Money Managers
Screen money managers from public funds and ETFs managed around the world